Open AccessRole of positron emission tomography/computed tomography in the evaluation of renal cell carcinoma
Author(s) -
Rahul Jena,
Tushar Aditya Narain,
Uday Pratap Singh,
Aneesh Srivastava
Publication year - 2021
Publication title -
indian journal of urology/indian journal of urology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.333
H-Index - 30
eISSN - 1998-3824
pISSN - 0970-1591
DOI - 10.4103/iju.iju_268_20
Subject(s) - medicine , positron emission tomography , renal cell carcinoma , radiology , positron emission tomography computed tomography , computed tomography , pet ct , nuclear medicine , medline , meta analysis , medical physics , oncology , political science , law
Positron emission tomography (PET) is not a standard recommendation in most of the major guidelines for the evaluation of renal cell carcinoma (RCC). Earlier studies evaluating PET scan in patients with RCC have provided discordant results. However, with the advent of newer hybrid PET/computed tomography (CT) scanning systems, this modality has shown increased efficacy in the evaluation of primary renal masses along with the detection of extrarenal metastases, restaging recurrent RCC, and also in monitoring response to targeted therapy. We performed a systematic review of the existing literature on the role of PET scan in the evaluation of RCC.